Literature DB >> 22807965

Two papillary renal cell carcinomas of different origin following renal transplantation (Case report).

Hans-Ulrich Gerth1, Michele Pohlen, Nils-Heinrich Thoennissen, Barbara Suwelack, Hermann-Josef Pavenstädt, Stefan Störkel, Mahmoud Abbas, Tilmann Spieker, Gerold Thölking.   

Abstract

Papillary renal cell carcinoma (PRCC) is a rare malignant tumor entity compared to common clear cell renal carcinoma. In the present study, we report a patient who was diagnosed with PRCC twice and successfully treated each time following renal transplantation. The first PRCC was located in the left native kidney two years following transplantation, and the second PRCC was diagnosed in the allograft 13 years following transplantation. The two tumors were completely removed by surgery in stage I of the disease with sufficient conservation of the allograft function. Notably, the tumors had a different origin as indicated by the microsatellite analysis, which reflects the exceptional course of the case. Risk factors for PRCC were identified in our patient. We concluded that high-risk candidates for malignancies in renal transplant recipients should receive shorter ultrasonic screening intervals, which may facilitate early tumor detection and improve outcome rates.

Entities:  

Year:  2012        PMID: 22807965      PMCID: PMC3398374          DOI: 10.3892/ol.2012.704

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

Review 1.  Malignancy in renal transplantation.

Authors:  Christian Morath; Martina Mueller; Hartmut Goldschmidt; Vedat Schwenger; Gerhard Opelz; Martin Zeier
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

2.  De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients.

Authors:  Igor Tsaur; Nicholas Obermüller; Dietger Jonas; Roman Blaheta; Eva Juengel; Ernst-Heinrich Scheuermann; Heinz-Georg Kachel; Athanasios Karalis; Michael Probst
Journal:  BJU Int       Date:  2010-11-10       Impact factor: 5.588

3.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Marc Colombel; Laurence Klotz; Eila Skinner; Thomas Keane; Sandrine Marreaud; Sandra Collette; Richard Sylvester
Journal:  Eur Urol       Date:  2010-12-22       Impact factor: 20.096

4.  Renal cell carcinoma of native kidneys in renal transplant recipients.

Authors:  N Ishikawa; K Tanabe; T Tokumoto; S Koga; H Okuda; H Nakazawa; K Takahashi; H Toma
Journal:  Transplant Proc       Date:  1998-11       Impact factor: 1.066

5.  Cancer risk after renal transplantation in Japan.

Authors:  Y Hoshida; H Tsukuma; Y Yasunaga; N Xu; M Q Fujita; T Satoh; Y Ichikawa; K Kurihara; M Imanishi; T Matsuno; K Aozasa
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

6.  Oncologic long-term outcome of elective nephron-sparing surgery versus radical nephrectomy in patients with renal cell carcinoma stage pT1b or greater in a matched-pair cohort.

Authors:  Frederik C Roos; Walburgis Brenner; Melanie Müller; Claudia Schubert; Wolfgang J Jäger; Joachim W Thüroff; Christian Hampel
Journal:  Urology       Date:  2010-12-08       Impact factor: 2.649

7.  Cancer risk in patients on dialysis and after renal transplantation.

Authors:  S A Birkeland; H Løkkegaard; H H Storm
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

8.  Primary kidney tumors before and after renal transplantation.

Authors:  I Penn
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

9.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

10.  Renal cell carcinoma in transplant recipients with acquired cystic kidney disease.

Authors:  Anke Schwarz; Serap Vatandaslar; Saskia Merkel; Hermann Haller
Journal:  Clin J Am Soc Nephrol       Date:  2007-04-25       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.